Suivre
Dr. med. Khalifa El Malki
Dr. med. Khalifa El Malki
Institut für Molekulare Medizin, Universitätsmedizin Mainz
Adresse e-mail validée de uni-mainz.de
Titre
Citée par
Citée par
Année
CD19 isoforms enabling resistance to CART-19 immunotherapy are expressed in B-ALL patients at initial diagnosis
J Fischer, C Paret, K El Malki, F Alt, A Wingerter, MA Neu, B Kron, ...
Journal of Immunotherapy 40 (5), 187-195, 2017
2172017
An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling
K El Malki, SH Karbach, J Huppert, M Zayoud, S Reißig, R Schüler, ...
Journal of Investigative Dermatology 133 (2), 441-451, 2013
1772013
Prospective analysis of long-term renal function in survivors of childhood Wilms tumor
MA Neu, A Russo, A Wingerter, F Alt, J Theruvath, K El Malki, B Kron, ...
Pediatric nephrology 32, 1915-1925, 2017
492017
Benefits of exercise training for children and adolescents undergoing cancer treatment: results from the randomized controlled MUCKI trial
S Stössel, MA Neu, A Wingerter, W Bloch, P Zimmer, C Paret, KE Malki, ...
Frontiers in Pediatrics 8, 243, 2020
462020
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy
C Paret, J Theruvath, A Russo, B Kron, K El Malki, N Lehmann, ...
Oncotarget 7 (50), 83378, 2016
352016
Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy
C Paret, A Russo, H Otto, A Mayer, S Zahnreich, W Wagner, D Samuel, ...
Oncotarget 8 (69), 114210, 2017
292017
Susceptibility-weighted magnetic resonance imaging of cerebrovascular sequelae after radiotherapy for pediatric brain tumors
MA Neu, Y Tanyildizi, A Wingerter, N Henninger, K El Malki, F Alt, B Doerr, ...
Radiotherapy and Oncology 127 (2), 280-286, 2018
232018
Subclinical CNS inflammation as response to a myelin antigen in humanized mice
M Zayoud, K El Malki, K Frauenknecht, B Trinschek, L Kloos, K Karram, ...
Journal of Neuroimmune Pharmacology 8, 1037-1047, 2013
212013
Exploiting gangliosides for the therapy of Ewing’s sarcoma and H3K27M-mutant diffuse midline glioma
A Wingerter, K El Malki, R Sandhoff, L Seidmann, DC Wagner, ...
Cancers 13 (3), 520, 2021
192021
Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma
O Beck, C Paret, A Russo, J Burhenne, M Fresnais, K Steimel, ...
Cancers 12 (4), 793, 2020
172020
Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients
M Winker, S Stössel, MA Neu, N Lehmann, K El Malki, C Paret, N Joisten, ...
Supportive Care in Cancer, 1-4, 2022
132022
Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro-and neuroblastoma
J Theruvath, A Russo, B Kron, C Paret, A Wingerter, K El Malki, MA Neu, ...
Pediatric hematology and oncology 33 (4), 264-275, 2016
92016
Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells
N Lehmann, C Paret, K El Malki, A Russo, MA Neu, A Wingerter, ...
Frontiers in Immunology 11, 1819, 2020
52020
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1
C Paret, N Lehmann, H Bender, M Sprang, CJ Sommer, D Cana, ...
Cancers 13 (22), 5838, 2021
42021
IL-17 signaling in keratinocytes orchestrates the defense against Staphylococcus aureus skin infection
S Moos, T Regen, F Wanke, Y Tian, LT Arendholz, J Hauptmann, ...
Journal of Investigative Dermatology 143 (7), 1257-1267. e10, 2023
32023
Glucosylceramide synthase inhibitors induce ceramide accumulation and sensitize H3K27 mutant diffuse midline glioma to irradiation
K El Malki, P Wehling, F Alt, R Sandhoff, S Zahnreich, A Ustjanzew, ...
International journal of molecular sciences 24 (12), 9905, 2023
22023
Hemophagocytic lymphohistiocytosis in early infancy-pitfall of differentiation between hereditary and infectious reasons
A Russo, F Alt, MA Neu, S Eder, A Wingerter, K El Malki, B Lammle, ...
Blood 132, 4961, 2018
22018
GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype
C Paret, A Ustjanzew, S Ersali, L Seidmann, R Jennemann, N Ziegler, ...
Cancers 14 (24), 6051, 2022
12022
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL
N Ziegler, M Cortés-López, F Alt, M Sprang, A Ustjanzew, N Lehmann, ...
Oncoimmunology 12 (1), 2184143, 2023
2023
EXPLOITING GLYCOSPHINGOLIPIDS FOR THE CLASSIFICATION AND TREATMENT OF PAEDIATRIC TUMOURS OF THE PERIPHERAL AND CENTRAL NERVOUS SYSTEM
C Paret, S Ersali, L Seidmann, A Russo, A Wingerter, K El Malki, ...
PEDIATRIC BLOOD & CANCER 70, 2023
2023
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20